JPWO2023277120A1 - - Google Patents
Info
- Publication number
- JPWO2023277120A1 JPWO2023277120A1 JP2023532045A JP2023532045A JPWO2023277120A1 JP WO2023277120 A1 JPWO2023277120 A1 JP WO2023277120A1 JP 2023532045 A JP2023532045 A JP 2023532045A JP 2023532045 A JP2023532045 A JP 2023532045A JP WO2023277120 A1 JPWO2023277120 A1 JP WO2023277120A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024067062A JP7839217B2 (ja) | 2021-06-30 | 2024-04-17 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021108230 | 2021-06-30 | ||
| JP2021108230 | 2021-06-30 | ||
| PCT/JP2022/026168 WO2023277120A1 (ja) | 2021-06-30 | 2022-06-30 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024067062A Division JP7839217B2 (ja) | 2021-06-30 | 2024-04-17 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023277120A1 true JPWO2023277120A1 (https=) | 2023-01-05 |
| JP7476431B2 JP7476431B2 (ja) | 2024-04-30 |
Family
ID=84691891
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532045A Active JP7476431B2 (ja) | 2021-06-30 | 2022-06-30 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
| JP2024067062A Active JP7839217B2 (ja) | 2021-06-30 | 2024-04-17 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024067062A Active JP7839217B2 (ja) | 2021-06-30 | 2024-04-17 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240309010A1 (https=) |
| EP (1) | EP4365174A4 (https=) |
| JP (2) | JP7476431B2 (https=) |
| KR (1) | KR20240027603A (https=) |
| CN (2) | CN121873082A (https=) |
| AR (1) | AR126290A1 (https=) |
| AU (1) | AU2022300611A1 (https=) |
| BR (1) | BR112023025934A2 (https=) |
| CA (1) | CA3223354A1 (https=) |
| IL (1) | IL309736A (https=) |
| MX (1) | MX2023014123A (https=) |
| WO (1) | WO2023277120A1 (https=) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015005429A1 (ja) * | 2013-07-10 | 2015-01-15 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
| WO2018124060A1 (ja) * | 2016-12-26 | 2018-07-05 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規化合物及びその薬理的に許容される塩 |
| WO2020004521A1 (ja) * | 2018-06-27 | 2020-01-02 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 炎症性疾患、自己免疫疾患、線維化疾患、及びがん疾患の治療剤 |
| WO2020004518A1 (ja) * | 2018-06-27 | 2020-01-02 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
-
2022
- 2022-06-30 MX MX2023014123A patent/MX2023014123A/es unknown
- 2022-06-30 JP JP2023532045A patent/JP7476431B2/ja active Active
- 2022-06-30 CN CN202610020318.9A patent/CN121873082A/zh active Pending
- 2022-06-30 IL IL309736A patent/IL309736A/en unknown
- 2022-06-30 CA CA3223354A patent/CA3223354A1/en active Pending
- 2022-06-30 KR KR1020237043708A patent/KR20240027603A/ko active Pending
- 2022-06-30 WO PCT/JP2022/026168 patent/WO2023277120A1/ja not_active Ceased
- 2022-06-30 EP EP22833266.4A patent/EP4365174A4/en active Pending
- 2022-06-30 BR BR112023025934A patent/BR112023025934A2/pt unknown
- 2022-06-30 AU AU2022300611A patent/AU2022300611A1/en active Pending
- 2022-06-30 AR ARP220101722A patent/AR126290A1/es unknown
- 2022-06-30 US US18/575,158 patent/US20240309010A1/en active Pending
- 2022-06-30 CN CN202280035356.1A patent/CN117295744A/zh active Pending
-
2024
- 2024-04-17 JP JP2024067062A patent/JP7839217B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015005429A1 (ja) * | 2013-07-10 | 2015-01-15 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
| WO2018124060A1 (ja) * | 2016-12-26 | 2018-07-05 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規化合物及びその薬理的に許容される塩 |
| WO2020004521A1 (ja) * | 2018-06-27 | 2020-01-02 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 炎症性疾患、自己免疫疾患、線維化疾患、及びがん疾患の治療剤 |
| WO2020004518A1 (ja) * | 2018-06-27 | 2020-01-02 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7839217B2 (ja) | 2026-04-01 |
| CN117295744A (zh) | 2023-12-26 |
| EP4365174A4 (en) | 2025-07-02 |
| US20240309010A1 (en) | 2024-09-19 |
| KR20240027603A (ko) | 2024-03-04 |
| MX2023014123A (es) | 2023-12-12 |
| BR112023025934A2 (pt) | 2024-02-27 |
| JP7476431B2 (ja) | 2024-04-30 |
| EP4365174A1 (en) | 2024-05-08 |
| AU2022300611A1 (en) | 2024-01-25 |
| WO2023277120A1 (ja) | 2023-01-05 |
| CN121873082A (zh) | 2026-04-17 |
| AR126290A1 (es) | 2023-10-04 |
| TW202311242A (zh) | 2023-03-16 |
| JP2024096941A (ja) | 2024-07-17 |
| IL309736A (en) | 2024-02-01 |
| CA3223354A1 (en) | 2023-01-05 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230818 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230818 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231013 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231206 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240208 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240321 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240417 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7476431 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |